Pricing

Log inSign up

Aura Biosciences

86 people · 0 jobs
‌

Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach they call molecular surgery.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Elisabet de los Pinos
CEO
Collapse
Joseph Lyons
Vice President Human Resources
Sharon A. Malia
Vice President, Quality
BS
Balcar Singh
Vice President, Global Product Supply
Manas Ray
Executive Director
PN
Patrick Nealon
Senior Vice President Clinical Development Operations
Mark Plavsic
Chief Technology Officer
Amy Elazzouzi
VP, Finance
CK
Conor Kilroy
Chief Legal Officer
AG
Amanda G.
Senior Executive Assistant To The CEO And CFO
Mahindra Mohan
Vice President, Commercial Strategy And Business Development
Richard Mountfield
Senior Vice President, Regulatory Affairs And Quality At Aura Biosciences
Joe McQuaid
Clinical Lead, Urologic Oncology | Executive Director, Clinical Development

Board & advisors

David Johnson
Chairman
GM
Giovanni Mariggi
Director
AM
Antony Mattessich
Director
RP
Raj Parekh
Director
Sapna Srivastava
Director
KT
Karan Takhar
Director
JS
John T. Schiller
Scientific Founder
CS
Carol L. Shields
Advisor
EG
Evangelos Gragoudas
Advisor
AS
Arun D. Singh
Advisor
JD
Jay S. Duker
Advisor
BM
Brian Marr
Advisor
RC
Richard Carvajal
Advisor
AA
Andrea Apolo
Advisor
TB
Trinity J. Bivalacqua
Advisor
IK
Isaac Kim
Advisor
SL
Seth P. Lerner
Advisor
MK
Max Kates
Advisor
NS
Neal Shore
Advisor

Similar companies

Tango Therapeutics

3 followers

Cellares

5 followers

Gilead Sciences

171 followers

Regeneron

144 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

GRAIL

30 followers

Cytiva

19 followers

PerkinElmer

12 followers

Explore companies